tirzepatide glucagon retatrutide ly3437943 triple agonist glp-1 gip mechanism Beyond GLP-1: Retatrutide's triple-agonist (GLP-1, GIP, glucagon) is redefining metabolic health. Phase 2 data shows ~24% weight loss—surpassing semaglutide & tirzepatide. Evidence-based Full article: Tirzepatide for overweight

Nano-formulation of darkness hormone could be therapeutic solution for Parkinson's disease Scientists have proved that nano-formulation of Melatonin, the hormone produced by the brain in response to darkness, showed improved antioxidative and neuroprotective properties and could be a potential therapeutic solution for Parkinson's disease (PD)

Synaptic plasticity in the mesolimbic dopamine system

How it works

Physical activity, sedentary behaviour and risk of oesophago-gastric cancer: a prospective cohort study within UK Biobank

The authors also found a decrease in GSH concentration in premature infants with IRDS [40]

If you do end up having a drink, dont be too hard on yourself about losing progress